Poly(lactic-co-glycolic) acid-controlled-release systems: Experimental and modeling insights

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 30, Issue 3, 2013, Pages 257-276

  Hines, Daniel J ^a   Kaplan, David L ^a  

^a Tufts University   (United States)

Author keywords

Controlled release; Mathematical modeling; PGA; PLA; PLGA

Indexed keywords

MOLECULAR SCAFFOLD; POLYGLACTIN;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; CONTROLLED DRUG RELEASE; DEGRADATION KINETICS; DRUG FORMULATION; DRUG HYDROLYSIS; DRUG SPECIFICITY; DRUG STABILITY; GEL PERMEATION CHROMATOGRAPHY; GLASS TRANSITION TEMPERATURE; HYDROPHILICITY; HYDROPHOBICITY; IMMUNOGENICITY; MATHEMATICAL MODEL; NANOENCAPSULATION; TISSUE ENGINEERING;

ANIMALS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; HUMANS; KINETICS; LACTIC ACID; MODELS, CHEMICAL; PHARMACEUTICAL PREPARATIONS; POLYGLYCOLIC ACID; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL;

EID: 84876763378     PISSN: 07434863     EISSN: 2162660X     Source Type: Journal    
DOI: 10.1615/CritRevTherDrugCarrierSyst.2013006475     Document Type: Article

References (77)

1. Hui HW, Robinson JR, Lee VHL. Design and fabrication of oral controlled release drug delivery systems. In: Robinson JR, Lee VHL, editors. Controlled drug delivery: fundamentals and applications. New York: Marcel Dekker; 1987.
2. Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM. Polymeric systems for controlled drug release. Chem Rev. 1999;99:3181-98
3. Drake CF, Arch AJ, Inventors. Standard Telephones and Cables Public Limited Company, assignee. Controlled release system. United States patent US 4866097. 1989 Sept 12
4. Langer R, Peppas N. Chemical and physical structure of polymers as carriers for controlled release of bioactive agents: a review. J Macromol Sci C Polymer Rev. 1983;23:61-126
5. Shaviv A, Mikkelsen R. Controlled-release fertilizers to increase efficiency of nutrient use and minimize environmental degradation: a review. Nutrient Cycl Agroecosys. 1993;35:1-12
6. Madene A, Jacquot M, Scher J, Desobry S. Flavour encapsulation and controlled release? A review. Int J Food Sci Tech. 2006;41:1-21
7. Gerstl Z, Nasser A, Mingelgrin U. Controlled release of pesticides into water from clay-polymer formulations. J Agric Food Chem. 1998;46:3803-9
8. Brannon-Peppas L. Controlled release in the food and cosmetics industries. In: Polymeric Delivery Systems. ACS Symposium Series. Vol. 520. Washington, DC: American Chemical Society; 1993. p. 42-52
9. Pillai O, Panchagnula R. Polymers in drug delivery. Curr Opin Chem Biol. 2001;5:447-51
10. Herrero-Vanrell R, Rincón AC, Alonso M, Reboto V, Molina-Martinez IT, Rodríguez-Cabello JC. Self-assembled particles of an elastin-like polymer as vehicles for controlled drug release. J Control Release. 2005;102:113-22
11. Crotts G, Park TG. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microsph-eres: release kinetics and stability issues. J Microencapsul. 1998;15:699-713
12. Cutright DE, Beasley III JD, Perez B. Histologic comparison of polylactic and polyglycolic acid sutures. Oral Surg Oral Med Oral Pathol. 1971;32:165-73
13. Frazza EJ, Schmitt EE. A new absorbable suture. J Biomed Mater Res. 1971;5:43-58
14. Middleton JC, Tipton AJ. Synthetic biodegradable polymers as orthopedic devices. Biomaterials. 2000;21:2335-46
15. Racey GL, Wallace WR, Cavalaris CJ, Marguard JV. Comparison of a polyglycolic-polylactic acid suture to black silk and plain catgut in human oral tissues. J Oral Surg. 1978;36:766-70
16. Freiberg S, Zhu XX. Polymer microspheres for controlled drug release. Int J Pharm. 2004;282: 1-18
17. Kitchell JP, Wise DL. Poly(lactic/glycolic acid) biodegradable drug-polymer matrix systems. Methods Enzymol. 1985;112:436-48
18. Chen L, Apte RN, Cohen S. Characterization of PLGA microspheres for the controlled delivery of IL-1α for tumor immunotherapy. J Control Release. 1997;43:261-72
19. Han M. Biodegradable membranes for the controlled release of progesterone. 1. Characterization of membrane morphologies coagulated from PLGA/progesterone/DMF solutions. J Appl Polym Sci. 2000;75:60-7
20. Wang YM, Sato H, Horikoshi I. In vitro and in vivo evaluation of taxol release from poly(lactic-coglycolic acid) microspheres containing isopropyl myristate and degradation of the microspheres. J Control Release. 1997;49:157-66
21. Kawashima Y, Yamamoto H, Takeuchi H, Fujioka S, Hino T. Pulmonary delivery of insulin with nebulized dl-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. J Control Release. 1999;62:279-87
22. Price JS, Tencer AF, Arm DM, Bohach GA. Controlled release of antibiotics from coated orthopedic implants. J Biomed Mater Res. 1996;30:281-6
23. Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials. 2000;21:2475-90
24. Champion JA, Katare YK, Mitragotri S. Particle shape: anew design parameter for micro- and nanoscale drug delivery carriers. J Control Release. 2007;121:3-9
25. Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28:5-24
26. Houchin ML, Topp EM. Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms. J Pharm Sci. 2008;97:2395-404
27. Kenley RA, Lee MO, Mahoney TR, Sanders LM. Poly(lactide-co-glycolide) decomposition kinetics in vivo and in vitro. Macromolecules. 1987;20:2398-403
28. Siepmann J, Elkharraz K, Siepmann F, Klose D. How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment. Biomacromolecules. 2005;6:2312-9
29. Vert M, Mauduit J, Li S. Biodegradation of PLA/GA polymers: increasing complexity. Biomaterials. 1994;15:1209-13
30. Lin Y, Feng C, Ye S, Lin Y, Chen C, Liao C, Chang K, Tsay R. An in vivo study on the biocompatibility of a bioresorbable poly(L-lactide-co-glycolide) pin for bone fixation. J Med Biol Eng. 2001;21:233
31. Siegel SJ, Kahn JB, Metzger K, Winey KI, Werner K, Dan N. Effect of drug type on the degradation rate of PLGA matrices. Eur J Pharm Biopharm. 2006;64:287-93
32. Faisant N, Siepmann J, Benoit JP. PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release. Eur J Pharm Sci. 2002;15:355-66
33. Varde NK. Elucidation of drug release mechanisms in PLGA microspheres [thesis]. Urbana-Champaign (IL): University of Illinois; 2007
34. Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled dr ug delivery carrier. Polymers. 2011;3:1377-97
35. Friess W, Schlapp M. Release mechanisms from gentamicin loaded poly(lactic-co-glycolic acid) (PLGA) microparticles. J Pharm Sci. 2002;91:845-55
36. Herrera LC, Tesoriero MVD, Hermida LG. In vitro release testing of PLGA microspheres with Franz diffusion cells. In Vitro. 2012;19:6-11
37. Klose D, Siepmann F, Elkharraz K, Krenzlin S, Siepmann J. How porosity and size affect the drug release mechanisms from PLGA-based microparticles. Int J Pharm. 2006;314:198-206
38. Park TG, Yong Lee H, Sung Nam Y. A new preparation method for protein loaded poly (D,Llactic- co-glycolic acid) microspheres and protein release mechanism study. J Control Release. 1998;55:181-91
39. Joung YK. PLGA microparticle-embedded thermosensitive hydrogels for sustained release of hydrophobic drugs. Biomed Mater. 2007;2:269-73
40. Galeska I, Kim T, Patil S, Bhardwaj U, Chatttopadhyay D, Papadimitrakopoulos F, Burgess DJ. Controlled release of dexamethasone from PLGA microspheres embedded within polyacid-containing PVA hydrogels. AAPS J. 2005;7:E231-40
41. Liu J, Zhang S, Chen P, Cheng L, Zhou W, Tang W, Chen ZW, Ke CM. Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels. J Mater Sci Mater Med. 2007;18: 2205-10
42. Jeong B, Bae YH, Kim SW. Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers. J Control Release. 2000;63:155-63
43. Li Y, Pei Y, Zhang X, Gu Z, Zhou Z, Yuan W, Zhou J, Zhu J, Gao X. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release. 2001;71:203-11
44. Wang ZH, Wang ZY, Sun CS, Wang CY, Jiang TY, Wang SL. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain. Biomaterials. 2010;31:908-15
45. Chan JM, Zhang L, Yuet KP, Liao G, Rhee J, Langer R, Farokhzad OC. PLGA-lecithin-PEG core- shell nanoparticles for controlled drug delivery. Biomaterials. 2009;30:1627-34
46. Xu Q, Czernuszka JT. Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-coglycolic acid) microspheres. J Control Release. 2008;127:146-53
47. van de Weert M, Hennink WE, Jiskoot W. Protein Instability in poly(lactic-co-glycolic acid) microparticles. Pharm. 2000;17:1159-67
48. Giteau A, Venier-Julienne MC, Aubert-Pouëssel A, Benoit JP. How to achieve sustained and complete protein release from PLGA-based microparticles? Int J Pharm. 2008;350:14-26
49. Taluja A, Bae YH. Role of a novel multifunctional excipient poly(ethylene glycol)-block-oligo(vinyl sulfadimethoxine) in controlled release of lysozyme from PLGA microspheres. Int J Pharm. 2008;358:50-9
50. Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MNV. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release. 2007;119:77-85
51. Gasparini G, Kosvintsev SR, Stillwell MT, Holdich RG. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification. Colloids Surf B Biointerfaces. 2008;61:199-207
52. Jose MV, Thomas V, Johnson KT, Dean DR, Nyairo E. Aligned PLGA/HA nanofibrous nanocomposite scaffolds for bone tissue engineering. Acta Biomater. 2009;5:305-15
53. Jose MV, Thomas V, Dean DR, Nyairo E. Fabrication and characterization of aligned nanofibrous PLGA/Collagen blends as bone tissue scaffolds. Polymer. 2009;50:3778-85
54. Wenk E, Meinel AJ, Wildy S, Merkle HP, Meinel L. Microporous silk fibroin scaffolds embedding PLGA microparticles for controlled growth factor delivery in tissue engineering. Biomaterials. 2009;30:2571-81
55. Mondalek FG, Lawrence BJ, Kropp BP, Grady BP, Fung K, Madihally SV, Lin HK. The incorporation of poly(lactic-co-glycolic) acid nanoparticles into porcine small intestinal submucosa biomaterials. Biomaterials. 2008;29:1159-66
56. Klose D, Siepmann F, Elkharraz K, Siepmann J. PLGA-based drug delivery systems: 56. Importance of the type of drug and device geometry. Int J Pharm. 2008;354:95-103
57. Göpferich A. Mechanisms of polymer degradation and erosion. Biomaterials. 1996;17:103-14
58. Ritger PL, Peppas NA. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release. 1987;5:23-36
59. Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release. 1987;5:37-42
60. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2001;48:139-57
61. Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci. 1961;50:874-5
62. Paul DR, Harris FW. Controlled release polymeric formulations. Vol. 33. Washington, DC: American Chemical Society; 1976
63. Varelas CG, Dixon DG, Steiner CA. Zero-order release from biphasic polymer hydrogels. J Control Release. 1995;34:185-92
64. Gibaldi M, Feldman S. Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms. J Pharm Sci. 1967;56: 1238-42
65. Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation. Ind Eng Chem. 1931;23:923-31
66. Langenbucher F. Linearization of dissolution rate curves by the Weibull distribution. J Pharm Pharmacol. 1972;24:979-81
67. Harland RS, Gazzaniga A, Sangalli ME, Colombo P, Peppas NA. Drug/polymer matrix swelling and dissolution. Pharm Res. 1988;5:488-94
68. Wise DL, Trantolo DJ, Marino RT, Kitchell JP. Opportunities and challenges in the design of implantable biodegradable polymeric systems for the delivery of antimicrobial agents and vaccines. Adv Drug Deliv Rev. 1987;1:19-40
69. Chiu LK, Chiu WJ, Cheng Y. Effects of polymer degradation on drug released-mechanistic study of morphology and transport properties in 50:50 poly(dl-lactide-co-glycolide). Int J Pharm. 1995;126:169-78
70. Faisant N, Siepmann J, Richard J, Benoit JP. Mathematical modeling of drug release from bioerodible microparticles: effect of gamma-irradiation. Eur J Pharm Biopharm. 2003;56:271-9
71. Hsu Y, Gresser JD, Trantolo DJ, Lyons CM, Gangadharam PRJ, Wise DL. In vitro controlled release of isoniazid from poly (lactide-co-glycolide) matrices. J Control Release. 1994;31:223-8
72. Baker RW. Controlled release of bioactive materials: based on the Waltham (MA):
73. Gallagher KM, Corrigan OI. Mechanistic aspects of the release of levamisole hydrochloride from biodegradable polymers. J Control Release. 2000;69:261-72
74. Rothstein SN, Federspiel WJ, Little SR. A simple model framework for the prediction of controlled release from bulk eroding polymer matrices. J Mater Chem. 2008;18:1873-80
75. Budhian A, Siegel SJ, Winey KI. Controlling the in vitro release profiles for a system of haloperidolloaded PLGA nanoparticles. Int J Pharm. 2008;346:151-9
76. Lim T, Poh C, Wang W. Poly (lactic-co-glycolic acid) as a controlled release delivery device. J Mater Sci Mater Med. 2009;20:1669-75
77. Kost J, Langer R. Responsive polymeric delivery systems. Adv Drug Deliv Rev. 2001;46:125-48.